PANAGORA ASSET MANAGEMENT INC - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 126 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$123,125
+176.7%
66,554
+66.0%
0.00%
Q4 2022$44,497
-86.8%
40,087
-72.2%
0.00%
-100.0%
Q3 2022$338,000
+3.0%
144,287
+33.5%
0.00%0.0%
Q2 2022$328,000
-60.9%
108,115
-12.4%
0.00%
-60.0%
Q1 2022$838,000
-11.2%
123,351
+9.1%
0.01%0.0%
Q4 2021$944,000
+20.3%
113,065
+7.0%
0.01%
+25.0%
Q3 2021$785,000
+24.4%
105,696
+13.8%
0.00%
+33.3%
Q2 2021$631,000
+4407.1%
92,867
+6693.5%
0.00%
Q1 2021$14,000
+40.0%
1,3670.0%0.00%
Q4 2020$10,000
-58.3%
1,367
-52.8%
0.00%
Q3 2020$24,000
+60.0%
2,897
+29.7%
0.00%
Q2 2020$15,0000.0%2,233
-31.0%
0.00%
Q1 2020$15,000
-46.4%
3,2360.0%0.00%
Q4 2019$28,000
+154.5%
3,2360.0%0.00%
Q3 2019$11,000
+266.7%
3,236
+422.8%
0.00%
Q2 2019$3,000
-62.5%
619
+6.5%
0.00%
Q2 2017$8,000
-94.3%
581
-90.9%
0.00%
-100.0%
Q1 2017$141,0006,4130.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TRV GP II, LLC 9,200,349$64,402,00044.86%
TRV GP III, LLC 3,048,780$21,342,0001.83%
SILVERARC CAPITAL MANAGEMENT, LLC 406,665$2,847,0001.65%
Sofinnova Investments, Inc. 925,280$6,477,0000.39%
Omega Fund Management, LLC 334,965$2,345,0000.35%
Yorktown Management & Research Co Inc 49,200$344,0000.31%
Woodline Partners LP 940,902$6,586,0000.18%
HUSSMAN STRATEGIC ADVISORS, INC. 51,000$357,0000.09%
HORIZON FINANCIAL SERVICES, LLC 12,005$84,0000.08%
Gyon Technologies Capital Management, LP 26,893$188,0000.06%
View complete list of JOUNCE THERAPEUTICS INC shareholders